Shopping Cart
- Remove All
- Your shopping cart is currently empty
AZD0516 is a pioneering antibody-drug conjugate (ADC) targeting Six Transmembrane Epithelial Antigen of the Prostate 2 (STEAP2). It is composed of an anti-STEAP2 monoclonal antibody (mAb) linked via a cysteine-maleimide reactive, β-glucuronidase-cleavable linker to the topoisomerase 1 inhibitor Exatecan. AZD0516 is applicable for prostate cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | AZD0516 is a pioneering antibody-drug conjugate (ADC) targeting Six Transmembrane Epithelial Antigen of the Prostate 2 (STEAP2). It is composed of an anti-STEAP2 monoclonal antibody (mAb) linked via a cysteine-maleimide reactive, β-glucuronidase-cleavable linker to the topoisomerase 1 inhibitor Exatecan. AZD0516 is applicable for prostate cancer research. |
Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.